Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Importance: The US Preventive Services Task Force (USPSTF) is updating its 2013 lung cancer screening guidelines, which recommend annual screening for adults aged 55 through 80 years who have a smoking history of at least 30 pack-years and currently smoke or have quit within the past 15 years. Objective: To inform the USPSTF guidelines by estimating the benefits and harms associated with various low-dose computed tomography (LDCT) screening strategies. Design, Setting, and Participants: Comparative simulation modeling with 4 lung cancer natural history models for individuals from the 1950 and 1960 US birth cohorts who were followed up from aged 45 through 90 years. Exposures: Screening with varying starting ages, stopping ages, and screening frequency. Eligibility criteria based on age, cumulative pack-years, and years since quitting smoking (risk factor-based) or on age and individual lung cancer risk estimation using risk prediction models with varying eligibility thresholds (risk model-based). A total of 1092 LDCT screening strategies were modeled. Full uptake and adherence were assumed for all scenarios. Main Outcomes and Measures: Estimated lung cancer deaths averted and life-years gained (benefits) compared with no screening. Estimated lifetime number of LDCT screenings, false-positive results, biopsies, overdiagnosed cases, and radiation-related lung cancer deaths (harms). Results: Efficient screening programs estimated to yield the most benefits for a given number of screenings were identified. Most of the efficient risk factor-based strategies started screening at aged 50 or 55 years and stopped at aged 80 years. The 2013 USPSTF-recommended criteria were not among the efficient strategies for the 1960 US birth cohort. Annual strategies with a minimum criterion of 20 pack-years of smoking were efficient and, compared with the 2013 USPSTF-recommended criteria, were estimated to increase screening eligibility (20.6%-23.6% vs 14.1% of the population ever eligible), lung cancer deaths averted (469-558 per 100 000 vs 381 per 100 000), and life-years gained (6018-7596 per 100 000 vs 4882 per 100 000). However, these strategies were estimated to result in more false-positive test results (1.9-2.5 per person screened vs 1.9 per person screened with the USPSTF strategy), overdiagnosed lung cancer cases (83-94 per 100 000 vs 69 per 100 000), and radiation-related lung cancer deaths (29.0-42.5 per 100 000 vs 20.6 per 100 000). Risk model-based vs risk factor-based strategies were estimated to be associated with more benefits and fewer radiation-related deaths but more overdiagnosed cases. Conclusions and Relevance: Microsimulation modeling studies suggested that LDCT screening for lung cancer compared with no screening may increase lung cancer deaths averted and life-years gained when optimally targeted and implemented. Screening individuals at aged 50 or 55 years through aged 80 years with 20 pack-years or more of smoking exposure was estimated to result in more benefits than the 2013 USPSTF-recommended criteria and less disparity in screening eligibility by sex and race/ethnicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the efficiency of decision making units
Charnes, A., Cooper, W. W., & Rhodes, E. (1978) · European Journal of Operational Research · doi:10.1016/0377-2217(78)90138-8 · Cited by 29,767
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Self-citationSelection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Variations in Lung Cancer Risk Among Smokers
Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., & Begg, C. B. (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.470 · Cited by 642
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment
Pinsky, P. F., Gierada, D. S., Black, W., Munden, R., Nath, H., Aberle, D., & Kazerooni, E. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2086 · Cited by 508
Knudsen, A. B., Zauber, A. G., Rutter, C. M., Naber, S. K., Doria-Rose, V. P., Pabiniak, C., Johanson, C., Fischer, S. E., Lansdorp-Vogelaar, I., & Kuntz, K. M. (2016) · JAMA · doi:10.1001/jama.2016.6828 · Cited by 474
de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Self-citationLung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
(2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.044 · Cited by 464
Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial
Becker, N., Motsch, E., Trotter, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Kauczor, H., Maldonado, S. G., Miller, A. B., Kaaks, R., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32486 · Cited by 449
Translational Lung Cancer Research
(2016) · Translational Lung Cancer Research · doi:10.21037/tlcr · Cited by 412
Implementation of Lung Cancer Screening in the Veterans Health Administration
Kinsinger, L. S., Anderson, C., Kim, J., Larson, M., Chan, S. H., King, H. A., Rice, K. L., Slatore, C. G., Tanner, N. T., Pittman, K., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9022 · Cited by 366
Field, J. K., Duffy, S. W., Baldwin, D. R., Whynes, D. K., Devaraj, A., Brain, K. E., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207140 · Cited by 337
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
ten Haaf, K., Jeon, J., Tammemägi, M. C., Han, S. S., Kong, C. Y., Plevritis, S. K., Feuer, E. J., de Koning, H. J., Steyerberg, E. W., & Meza, R. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002277 · Cited by 284
Self-citationMandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1536 · Cited by 281
Self-citationCrosbie, P. A., Balata, H., Evison, M., Atack, M., Bayliss-Brideaux, V., Colligan, D., Duerden, R., Eaglesfield, J., Edwards, T., Elton, P., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2017-211377 · Cited by 242
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
Aldrich, M. C., Mercaldo, S. F., Sandler, K. L., Blot, W. J., Grogan, E. L., & Blume, J. D. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1402 · Cited by 230
Tammemagi, M. C., Schmidt, H., Martel, S., McWilliams, A., Goffin, J. R., Johnston, M. R., Nicholas, G., Tremblay, A., Bhatia, R., Liu, G., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30597-1 · Cited by 216
Jeon, J., Holford, T. R., Levy, D. T., Feuer, E. J., Cao, P., Tam, J., Clarke, L., Clarke, J., Kong, C. Y., & Meza, R. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1250 · Cited by 206
Self-citationImpact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
Moolgavkar, S. H., Holford, T. R., Levy, D. T., Kong, C. Y., Foy, M., Clarke, L., Jeon, J., Hazelton, W. D., Meza, R., Schultz, F., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs136 · Cited by 184
Self-citationKatki, H. A., Kovalchik, S. A., Petito, L. C., Cheung, L. C., Jacobs, E., Jemal, A., Berg, C. D., & Chaturvedi, A. K. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2701 · Cited by 184
Joseph, A. M., Rothman, A. J., Almirall, D., Begnaud, A., Chiles, C., Cinciripini, P. M., Fu, S. S., Graham, A. L., Lindgren, B. R., Melzer, A. C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0909ci · Cited by 147
Holford, T. R., Levy, D. T., & Meza, R. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv274 · Cited by 115
Self-citationHuo, J., Shen, C., Volk, R. J., & Shih, Y.-C. T. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9016 · Cited by 113
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
ten Haaf, K., Bastani, M., Cao, P., Jeon, J., Toumazis, I., Han, S. S., Plevritis, S. K., Blom, E. F., Kong, C. Y., Tammemägi, M. C., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz164 · Cited by 107
Self-citationRisk-Targeted Lung Cancer Screening
Kumar, V., Cohen, J. T., Klaveren, D. V., Soeteman, D. I., Wong, J. B., Neumann, P. J., & Kent, D. M. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1401 · Cited by 106
Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations
Richards, T. B., Doria-Rose, V. P., Soman, A., Klabunde, C. N., Caraballo, R. S., Gray, S. C., Houston, K. A., & White, M. C. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.07.030 · Cited by 97
ACR CT Accreditation Program and the Lung Cancer Screening Program Designation
Kazerooni, E. A., Armstrong, M. R., Amorosa, J. K., Hernandez, D., Liebscher, L. A., Nath, H. P., McNitt‐Gray, M. F., Stern, E. J., & Wilcox, P. A. (2016) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2015.12.010 · Cited by 91
Meza, R., ten Haaf, K., Kong, C. Y., Erdogan, S. A., Black, W. C., Tammemägi, M. C., Choi, S. E., Jeon, J., Han, S. S., Munshi, V. N., et al. (2014) · Cancer · doi:10.1002/cncr.28623 · Cited by 86
Self-citationCao, P., Jeon, J., Levy, D. T., Jayasekera, J. C., Cadham, C. J., Mandelblatt, J. S., Taylor, K. L., & Meza, R. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.008 · Cited by 83
Self-citationACR CT Accreditation Program and the Lung Cancer Screening Program Designation
Kazerooni, E. A., Armstrong, M. R., Amorosa, J. K., Hernandez, D., Liebscher, L. A., Nath, H. P., McNitt‐Gray, M. F., Stern, E. J., & Wilcox, P. A. (2014) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2014.10.002 · Cited by 81
Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial
Frille, A., Hardavella, G., & Lee, R. (2020) · Breathe · doi:10.1183/20734735.0322-2019 · Cited by 76
Trends in the Proportion of Patients With Lung Cancer Meeting Screening Criteria
Wang, Y., Midthun, D. E., Wampfler, J. A., Deng, B., Stoddard, S. M., Zhang, S., & Yang, P. (2015) · JAMA · doi:10.1001/jama.2015.413 · Cited by 74
Disparities of National Lung Cancer Screening Guidelines in the US Population
Han, S. S., Chow, E. K. H., ten Haaf, K., Toumazis, I., Cao, P., Bastani, M., Tammemägi, M. C., Jeon, J., Feuer, E. J., Meza, R., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa013 · Cited by 73
Self-citationSelecting lung cancer screenees using risk prediction models—where do we go from here
Tammemägi, M. C. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.06.03 · Cited by 61
Kathuria, H., Detterbeck, F. C., Fathi, J. T., Fennig, K., Gould, M. K., Jolicoeur, D. G., Land, S. R., Massetti, G. M., Mazzone, P. J., Silvestri, G. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1858st · Cited by 40
Meza, R., Jeon, J., Toumazis, I., et al. (2021) · Europe PMC (PubMed Central) · Cited by 11
Self-citation
Cited by
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102693 · Cited by 389
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., et al. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 310
Brims, F. J. H., Harris, E. J. A., Murray, C., Kumarasamy, C., Ho, A., Adler, B., Franklin, P., & de Klerk, N. H. (2023) · Respirology · doi:10.1111/resp.14487 · Cited by 16
Metadata
- Authors
- Meza, R., Jeon, J., Toumazis, I., ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., Plevritis, S. K., de Koning, H. J., & Kong, C. Y.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-09
- Volume
- 325
- Issue
- 10
- Pages
- 988
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3133859228
- Cited by
- 320
- References
- 42
- FWCI
- 32.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.